4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride
C16H29Cl2N3O2 — CID 171291953
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride
4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride (PubChem CID 171291953) has the molecular formula C16H29Cl2N3O2 and a molecular weight of 366.33 g/mol. Its IUPAC name is 4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride.
Molecular Properties
| Compound Name | 4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride |
|---|---|
| PubChem CID | 171291953 |
| Molecular Formula | C16H29Cl2N3O2 |
| Molecular Weight | 366.33 g/mol |
| Exact Mass | 365.16 |
| IUPAC Name | 4-[(1R)-2,2-dimethyl-1-piperazin-1-ylpropyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol;dihydrochloride |
| SMILES | Cc1ncc(CO)c([C@H](N2CCNCC2)C(C)(C)C)c1O.Cl.Cl |
| InChI | InChI=1S/C16H27N3O2.2ClH/c1-11-14(21)13(12(10-20)9-18-11)15(16(2,3)4)19-7-5-17-6-8-19;;/h9,15,17,20-21H,5-8,10H2,1-4H3;2*1H/t15-;;/m0../s1 |
| InChIKey | HKPQQZNUHPGWOJ-CKUXDGONSA-N |
| XLogP | 2.42 |
| TPSA | 68.62 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.33 |
| LogP ≤ 5 | 2.42 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171291953 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.